Gary Goldenberg

Insider Reports History

Location
West Chester, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gary Goldenberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. Chief Medical Officer Common Stock 94,261 $231,882 $2.46 27 Aug 2024 Direct
Verrica Pharmaceuticals Inc. Chief Medical Officer Employee Stock Option (right to buy) 80,000 15 Mar 2024 Direct

Insider Reports Filed by Gary Goldenberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRCA Verrica Pharmaceuticals Inc. 26 Aug 2024 2 -$35,161 4 Chief Medical Officer 28 Aug 2024, 16:15
VRCA Verrica Pharmaceuticals Inc. 22 Jul 2024 2 -$130,653 4 Chief Medical Officer 23 Jul 2024, 18:11
VRCA Verrica Pharmaceuticals Inc. 15 Mar 2024 2 $0 4 CHIEF MEDICAL OFFICER 19 Mar 2024, 16:31
VRCA Verrica Pharmaceuticals Inc. 14 Nov 2023 2 -$26,061 4 Chief Medical Officer 16 Nov 2023, 16:35
VRCA Verrica Pharmaceuticals Inc. 24 Aug 2023 1 $0 4/A Chief Medical Officer 06 Feb 2025, 16:15
VRCA Verrica Pharmaceuticals Inc. 21 Jul 2023 2 -$138,616 4 Chief Medical Officer 25 Jul 2023, 16:23
VRCA Verrica Pharmaceuticals Inc. 01 Mar 2023 1 $0 4 Chief Medical Officer 03 Mar 2023, 15:26
VRCA Verrica Pharmaceuticals Inc. 05 Jul 2022 1 +$49,999 4 Chief Medical Officer 05 Jul 2022, 16:12
VRCA Verrica Pharmaceuticals Inc. 24 Feb 2022 1 $0 4 Chief Medical Officer 25 Feb 2022, 15:36